总时间（秒）：31.58
问答时间（秒）：31.43

Okay, I'm ready to process the literature. Since I don't have any specific literature provided, I will create a *hypothetical* scenario and generate a JSON output based on it.

**Hypothetical Literature:**

"A study investigated the impact of a novel frameshift variant, c.1234_1235insT, in the *MYOTUBIN* gene in patients with Hereditary Myopathy. This variant, predicted to lead to a premature stop codon, results in a truncated protein of only 150 amino acids compared to the normal 750 amino acids. Western blot analysis using lysates from patient-derived fibroblasts showed a dramatic reduction in Myotubulin protein levels (approximately 10%) compared to controls. A second cohort of patients, carrying a missense variant, p.Arg457His, in the same gene, showed mild reduction in levels (approximately 20% reduction).  Fibroblasts were cultured in vitro and analyzed three times biologically and each condition was tested twice. A wild-type control cDNA was used to verify proper detection. HEK293 cells were also tested to further assess the variant."

**JSON Output:**

```json
{
  "Variants Include": [
    {
      "Gene": "MYOTUBIN",
      "variants": [
        {
          "HGVS": "NM_002022.4:c.1234_1235insT",
          "cDNA Change": {
            "transcript": "NM_002022.4",
            "ref": "N/A",
            "alt": "T",
            "position": "1234_1235"
          },
          "Protein Change": {
            "ref": "N/A",
            "alt": "Premature Stop Codon",
            "position": "N/A"
          },
          "Description in input context": "frameshift variant, predicted to lead to a premature stop codon."
        },
          {
            "Gene": "MYOTUBIN",
            "variants": [
              {
                "HGVS": "NM_002022.4:c.1234_1235insT",
                "cDNA Change": {
                    "transcript": "NM_002022.4",
                    "ref": "N/A",
                    "alt": "N/A",
                    "position": "N/A"
                },
                "Protein Change": {
                    "ref": "N/A",
                    "alt": "N/A",
                    "position": "N/A"
                },
                "Description in input context": "missense variant, p.Arg457His"
              }
            ]
          }
      ]
    },
    "Described Disease": {
      "Described Disease": "Hereditary Myopathy",
      "MONDO": "MONDO:0012345"
    },
    "Experiment Method": [
      {
        "Assay Method": "Western Blot",
        "Material used": {
          "Material Source": "Patients Derived Material",
          "Material Name": "Fibroblasts from patients with Hereditary Myopathy",
          "Description": "Lysates from patient-derived fibroblasts were used in the Western Blot analysis."
        },
        "Readout type": "Quantitative",
        "Readout description": [
          {
            "Variant": "NM_002022.4:c.1234_1235insT",
            "Conclusion": "Abnormal",
            "Molecular Effect": "complete loss-of-function",
            "Result Description": "Myotubulin protein levels were dramatically reduced (approximately 10%) compared to controls."
          },
          {
            "Variant": "NM_002022.4:c.1234_1235insT",
            "Conclusion": "Abnormal",
            "Molecular Effect": "complete loss-of-function",
            "Result Description": "Levels were drastically reduced at 10% compared to normal samples."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "Fibroblast cultures were analyzed three times biologically."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "Each condition was tested twice."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type control cDNA was used to verify proper detection."
        },
        "Basic negative control": {
          "Basic negative control": "N/A",
          "Description": "Not specifically mentioned in the provided literature."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N/A",
          "Counts": "N/A"
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N/A",
          "Counts": "N/A"
        },
        "Statistical analysis method": {
          "Statistical analysis method": "Not mentioned in provided literature"
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "Not described, determined by comparison to normal controls.",
          "Source": "Literature/Custom"
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "Protein expression less than a value considered normal, as determined by comparison to controls.",
          "Source": "Literature/Custom"
        },
        "Approved assay": {
          "Approved assay": "N/A"
        }
      }
    ]
  }
```

**Explanation of Choices:**

*   **HGVS Standardization:** I'm assuming a standard cDNA transcript and creating the HGVS nomenclature based on that.
*   **MONDO ID:**  I am using a general MONDO ID for Hereditary Myopathy as I don's have specific details. You'll need to update this with the specific ID if you have it.
*   **Molecular Effect:** Based on the premature stop codon, I have inferred a "complete loss-of-function".
*   **Readout Description:**  I'm including the quantitative details provided (approximately 10% reduction).
*   **Controls:** The description mentions a positive control (wild-type cDNA), but lacks negative control information.
*   **Thresholds:** I marked thresholds as "Literature/Custom," since the passage does not directly state a precise cut-off value.
*   **Approved Assay:** I marked as “N/A” due to lack of information

**To use this effectively:**

1.  **Provide the actual literature.**  I can then extract the specific details.
2.  **Specify the preferred MONDO ID.**
3.  **Indicate if you have any other specific preferences** in how I interpret the information (e.g., specific thresholds for abnormal results).

Let me know if you're ready to provide the literature!